Grant

Prospective Cohort to Evaluate the Immunogenicity and Effectiveness of COVID-19 Vaccines Among Previously Infected and Uninfected Essential and Frontline Workers in a US State or Region

Sponsored by Centers for Disease Control and Prevention

Active

$22.4M Funding

9 People

External

Related Topics

covid-19 vaccines, immunogenicity, effectiveness, frontline workers, prospective cohort

People

Karen Lutrick
Co-Investigator (COI)
Family and Community Medicine﹒Associate Professor
Shawn Beitel
(CD)
Community Environment & Policy﹒Research Program Administration Officer III
Jefferey Burgess
Principal Investigator (PI)
Community Environment & Policy﹒Professor
Jennifer Uhrlaub
(CD)
Immunobiology﹒Researcher/Scientist V
James Hollister
(CD)
Community Environment & Policy﹒Scientific Analyst I
Edward Bedrick
Co-Investigator (COI)
Epidemiology and Biostatistics﹒Professor
Janko Nikolich
Co-Investigator (COI)
Immunobiology﹒Department Head
Kate Ellingson
Co-Investigator (COI)
Epidemiology and Biostatistics﹒Associate Professor
Ryan Sprissler
(CD)
Research, Innovation & Impact Core Facilities﹒Associate Research Professor